神经内镜与钻孔引流治疗大量慢性硬膜下血肿的疗效及安全性

doi:10.6040/j.issn.1671-7554.0.2023.0490

摘要/Abstract

摘要： 目的探讨神经内镜与钻孔引流治疗慢性硬膜下血肿(CSDH)的疗效及安全性。方法收集2020年1月至 2022年12月我科收治的117例大量慢性硬膜下血肿患者的临床资料并进行回顾性分析,依据手术方法差异,将患者分为两组,内镜组 52例,钻孔引流组 65 例。比较两组患者的一般情况、CT表现、临床疗效、术后并发症及3个月后复发情况。结果内镜组患者术后引流管留置时间以及住院时间更短,术后1周的血肿清除率更高(P<0.05);两组患者术后并发症发生率差异无统计学意义,内镜组患者3个月随访时预后更佳。结论神经内镜与钻孔引流均能有效治疗CSDH,同时神经内镜术后血肿清除率更高,留置引流管及住院时间短,在治疗慢性硬膜下血肿尤其是混杂密度血肿方面具有更好的临床疗效。

关键词: 慢性硬膜下血肿, 神经内镜, 钻孔引流, 安全性

Abstract: Objective To investigate the efficacy and safety of neuroendoscopy and borehole drainage in the treatment of chronic subdural hematoma(CSDH). Methods Clinical data of 117 CSDH patients hospitalized in our department during Jan. 2020 and Dec. 2022 were retrospectively analyzed. The patients were divided into two groups according to the surgical approaches, 52 cases in the neuroendoscopic group and 65 cases in the borehole drainage group. The demography, CT imaging, clinical efficacy, postoperative complications and recurrence rate were compared between the two groups. Results Compared with the borehole drainage group, the neuroendoscopic group had a shorter drainage tube retention time and hospital stay, and higher hematoma clearance rate(P<0.05), but longer operation time. There was no significant difference in the incidence of postoperative complications between the two groups. The neuroendoscopic group had a better prognosis at the 3-month follow-up. Conclusion Both neuroendoscopy and borehole drainage can effectively treat CSDH, while neuroendoscopy has a higher hematoma clearance rate, shorter retention of drainage tube and hospital stay, and better clinical efficacy.

Key words: Chronic subdural hematoma, Neuroendoscopy, Borehole drainage, Safety

中图分类号:

R651

钱明,姜雷,王学建,赵伟,汪志峰,张毅. 神经内镜与钻孔引流治疗大量慢性硬膜下血肿的疗效及安全性[J]. 山东大学学报 (医学版), 2023, 61(12): 94-99.

QIAN Ming, JIANG Lei, WANG Xuejian, ZHAO Wei, WANG Zhifeng, ZHANG Yi. Efficacy and safety of neuroendoscopy and borehole drainage in the treatment of massive chronic subdural hematoma[J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 94-99.

参考文献

[1] Almenawer SA, Farrokhyar F, Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients [J]. AnnSurg, 2014, 259(3): 449-457.
[2] Matsumoto H, Hanayama H, Okada T, et al. Clinical investigation of chronic subdural hematoma with impending brain herniation on arrival [J]. Neurosurg Rev, 2018,41(2): 447-455.
[3] Zeng L, Yu J, Chen R, et al. Modified valsalva maneuver after burr-hole drainage of chronic subdural hematomas: a single-center cohort study [J]. Front Neurol, 2022, 13: 1069708. doi: 10.3389/fneur.2022.1069708.
[4] Zhang J, Chen J. The therapeutic effects of craniotomy versus endoscopic-assisted trepanation drainage for isolated chronic subdural haematoma(ICSH): a single-centre long-term retrospective comparison study [J]. Brain Res Bull, 2020, 161: 94-97. doi: 10.1016/j.brainresbull.2020.04.014.
[5] Chen J, Xu J, Malkasian D, et al. The mini-craniotomy for cSDH revisited: new perspectives [J]. Front Neurol, 2021, 12: 660885. doi: 10.3389/fneur.2021.660885.
[6] Saway B, Roth W, Salvador C, et al. Subdural evacuation port system and middle meningeal artery embolization for chronic subdural hematoma: a multicenter experience [J]. J Neurosurg, 2023, 139(1): 131-138.
[7] Desir L, Narayan V, Ellis J, et al. Middle meningeal artery embolization in the management of chronic subdural hematoma: a comprehensive review of current literature [J]. Curr Neurol Neurosci Rep, 2023, 23(4): 109-119.
[8] Salih M, Shutran M, Young M, et al. Reduced recurrence of chronic subdural hematomas treated with open surgery followed by middle meningeal artery embolization compared to open surgery alone: a propensity score-matched analysis [J]. J Neurosurg, 2023, 139(1): 124-130.
[9] Bartley A, Bartek J, Jakola A, et al. Effect of irrigation fluid temperature on recurrence in the evacuation of chronic subdural hematoma: a randomized clinical trial [J]. JAMA Neurology, 2023, 80(1): 58-63.
[10] Markwalder T. The course of chronic subdural hematomas after burr-hole craniostomy with and without closed-system drainage [J]. Neurosurg Clin N Am, 2000, 11(3): 541-546.
[11] Salih M, Young M, Garcia A, et al. Outcome of chronic subdural hematoma intervention in patients on long-term antiplatelet therapy-a propensity score matched analysis [J]. Neurosurgery, 2023, 93(3): 586-591.
[12] 江荣才,王硕,张建宁.药物将成为治疗慢性硬膜下血肿的新模式[J]. 中华医学杂志, 2020, 100(8): 561-562. JIANG Rongcai, WANG Shuo, ZHANG Jianning. New drug therapy for chronic subdural hematoma is changing the treatment mode of the disease [J]. National Medical Journal of China, 2020, 100(8): 561-562.
[13] Onyinzo C, Berlis A, Abel M, et al. Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone [J]. J Neurointerv Surg, 2022, 14(3): 297-300.
[14] Salih M, Young M, Shutran M, et al. Effect of long-term anticoagulant therapy on the outcome of chronic subdural hematoma: a propensity score-matched analysis [J]. J Neurosurg, 2023, 139(1): 194-200.
[15] Martinez-Gutierrez J, Zeineddine H, Nahhas M, et al. Middle meningeal artery embolization for chronic subdural hematomas with concurrent antithrombotics [J]. Neurosurgery, 2023, 92(2): 258-262.
[16] Singh H, Patir R, Vaishya S, et al. Endoscopic evacuation of septated chronic subdural hemorrhage - Technical considerations, results, and outcome [J]. Surg Neurol Int, 2022, 13: 8. doi: 10.25259/SNI_963_2021.
[17] Brennan PM, Kolias AG, Joannides AJ, et al. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom [J]. J Neurosurg, 2017, 124(3): 732-739.
[18] Tanaka T, Fujimoto S, Saito K, et al. Histological study of operated cases of chronic subdural hematoma in adults: relationship between dura mater and outer membrane [J]. No Shinkei Geka Neurological Surgery, 1997, 25(8): 701-705.
[19] Huang Y, Yang K, Lee T, et al. Bilateral chronic subdural hematoma: what is the clinical significance? [J]. Int J Surg, 2013, 11(7): 544-548.
[20] Lin M. Subdural lesions linking additional intracranial spaces and chronic subdural hematomas: a narrative review with mutual correlation and possible mechanisms behind high recurrence [J]. Diagnostics(Basel), 2023, 13(2): 235.
[21] Hong K, Hsu S, Chen C, et al. Endoscope-assisted manipulation of chronic subdural hematomas provides a novel solution for eliminating the septum and inner membrane leading to reduced recurrence [J]. In Vivo, 2022, 36(6): 2774-2779.
[22] Munoz-Bendix C, Pannewitz R, Remmel D, et al. Outcome following surgical treatment of chronic subdural hematoma in the oldest-old population [J]. Neurosurgical Review, 2017, 40(3): 461-468.
[23] Wu L, Guo X, Ou Y, et al. Efficacy analysis of neuroendoscopy-assisted burr-hole evacuation for chronic subdural hematoma: a systematic review and meta-analysis [J]. Neurosurg Rev, 2023, 46(1): 98.
[24] Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study [J]. J Neurosurg, 2004, 100(1): 24-32.
[25] Vychopen M, Güresir E, Wach J. Anti-inflammatory drug therapy in chronic subdural hematoma: a systematic review and meta-analysis of prospective randomized, double-blind and placebo-controlled trials [J]. Int J Mol Sci, 2022, 23(24): 16198. doi: 10.3390/ijms232416198.
[26] Guo S, Gao W, Cheng W, et al. Endoscope-assisted surgery vs. burr-hole craniostomy for the treatment of chronic subdural hematoma: a systemic review and meta-analysis [J]. Front Neurol, 2020, 11: 540911. doi: 10.3389/fneur.2020.540911.
[27] Hamou H, Alzaiyani M, Rossmann T, et al. Seizure after surgical treatment of chronic subdural hematoma-Associated factors and effect on outcome [J]. Front Neurol, 2022,13: 977329. doi: 10.3389/fneur.2022.977329.
[28] 孙涛,韩易,姜之全,等.改良护脑双腔引流管在慢性硬膜下血肿外引流术中的应用[J]. 中华医学杂志, 2018, 98(45): 3681-3685. SUN Tao, HAN Yi, JIANG Zhiquan, et al. Application of modified brain protection double-lumen drainage tube in external drainage of chronic subdural hematoma [J]. National Medical Journal of China, 2018, 98(45): 3681-3685.

相关文章 14

[1]	马翔,赵飞燕. 。卵子冷冻保存现状与进展[J]. 山东大学学报 (医学版), 2022, 60(9): 19-23.
[2]	刘斌,田海龙,危兆胜,洪涛,王志刚. 神经内镜下扩大经鼻蝶手术颈内动脉破裂2例报道并文献复习[J]. 山东大学学报 (医学版), 2019, 57(2): 120-124.
[3]	张迎春. 人类辅助生殖技术子代安全性问题[J]. 山东大学学报 (医学版), 2019, 57(10): 52-59.
[4]	律慧敏,张梦玮,牛李敏,曾惠爱,闫敏. 国产多西他赛单药治疗晚期乳腺癌的疗效及安全性[J]. 山东大学学报 (医学版), 2018, 56(1): 45-49.
[5]	焦凤萍,张海涛,赵英会,田兆菊,杨树林. 单纯疱疹病毒2型DNA疫苗在小鼠体内分布及安全性的初步分析[J]. 山东大学学报（医学版）, 2017, 55(7): 38-42.
[6]	刘松涛,沈斌,林辉,李香伟,温昭科. 全胸腔镜下心脏不停跳与停跳二尖瓣置换术的对比[J]. 山东大学学报（医学版）, 2016, 54(8): 39-43.
[7]	徐闯,戚大春,李贤让,祖萌,李健,刘明廷. 初次髋关节置换术后引流与否的Meta分析[J]. 山东大学学报（医学版）, 2016, 54(6): 43-49.
[8]	冯子超,王济潍,李超,李卫国,陈腾,马翔宇,徐淑军,李新钢. 单纯神经内镜在桥小脑角区的手术应用[J]. 山东大学学报（医学版）, 2016, 54(10): 71-75.
[9]	王济潍, 李超, 陈腾, 张文华, 李卫国, 马翔宇, 徐淑军, 李新钢. 单纯神经内镜下微血管减压术治疗原发性三叉神经痛[J]. 山东大学学报（医学版）, 2015, 53(4): 83-86.
[10]	王春来, 徐淑军, 王洪亮, 尚景瑞. 神经内镜下外伤性脑脊液鼻漏修补的临床研究[J]. 山东大学学报（医学版）, 2015, 53(3): 69-72.
[11]	徐然, 马翔宇, 李卫国, 李超, 张鑫, 徐淑军, 李新钢. 神经内镜下乙状窦后锁孔入路微血管减压术治疗面肌痉挛[J]. 山东大学学报（医学版）, 2015, 53(10): 55-57.
[12]	侯新国，周克华，甄晓慧，宋君，张亮，矫磊，陈丽. 重组人胰高血糖素样肽-1联合二甲双胍治疗2型糖尿病的有效性和安全性评价[J]. 山东大学学报(医学版), 2011, 49(11): 1-.
[13]	展如才1，李淑云2，张合林1. 立体定向辅助神经内镜超早期治疗脑内血肿的临床研究[J]. 山东大学学报(医学版), 2010, 48(12): 162-164.
[14]	. 酪酸菌对腹泻小鼠的治疗效果及其安全性[J]. 山东大学学报(医学版), 2009, 47(9): 32-35.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed